Literature DB >> 22362910

Intensive hemodialysis associates with improved survival compared with conventional hemodialysis.

Gihad E Nesrallah1, Robert M Lindsay, Meaghan S Cuerden, Amit X Garg, Friedrich Port, Peter C Austin, Louise M Moist, Andreas Pierratos, Christopher T Chan, Deborah Zimmerman, Robert S Lockridge, Cécile Couchoud, Charles Chazot, Norma Ofsthun, Adeera Levin, Michael Copland, Mark Courtney, Andrew Steele, Philip A McFarlane, Denis F Geary, Robert P Pauly, Paul Komenda, Rita S Suri.   

Abstract

Patients undergoing conventional maintenance hemodialysis typically receive three sessions per week, each lasting 2.5-5.5 hours. Recently, the use of more intensive hemodialysis (>5.5 hours, three to seven times per week) has increased, but the effects of these regimens on survival are uncertain. We conducted a retrospective cohort study to examine whether intensive hemodialysis associates with better survival than conventional hemodialysis. We identified 420 patients in the International Quotidian Dialysis Registry who received intensive home hemodialysis in France, the United States, and Canada between January 2000 and August 2010. We matched 338 of these patients to 1388 patients in the Dialysis Outcomes and Practice Patterns Study who received in-center conventional hemodialysis during the same time period by country, ESRD duration, and propensity score. The intensive hemodialysis group received a mean (SD) 4.8 (1.1) sessions per week with a mean treatment time of 7.4 (0.87) hours per session; the conventional group received three sessions per week with a mean treatment time of 3.9 (0.32) hours per session. During 3008 patient-years of follow-up, 45 (13%) of 338 patients receiving intensive hemodialysis died compared with 293 (21%) of 1388 patients receiving conventional hemodialysis (6.1 versus 10.5 deaths per 100 person-years; hazard ratio, 0.55 [95% confidence interval, 0.34-0.87]). The strength and direction of the observed association between intensive hemodialysis and improved survival were consistent across all prespecified subgroups and sensitivity analyses. In conclusion, there is a strong association between intensive home hemodialysis and improved survival, but whether this relationship is causal remains unknown.

Entities:  

Mesh:

Year:  2012        PMID: 22362910      PMCID: PMC3312510          DOI: 10.1681/ASN.2011070676

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  28 in total

Review 1.  Interaction revisited: the difference between two estimates.

Authors:  Douglas G Altman; J Martin Bland
Journal:  BMJ       Date:  2003-01-25

Review 2.  The logrank test.

Authors:  J Martin Bland; Douglas G Altman
Journal:  BMJ       Date:  2004-05-01

3.  An international registry to compare quotidian dialysis regimens with conventional thrice-weekly hemodialysis: why, how, and potential pitfalls.

Authors:  Gihad E Nesrallah; Louise M Moist; Christian Awaraji; Robert M Lindsay
Journal:  Semin Dial       Date:  2004 Mar-Apr       Impact factor: 3.455

Review 4.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

5.  Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS.

Authors:  R Saran; J L Bragg-Gresham; N W Levin; Z J Twardowski; V Wizemann; A Saito; N Kimata; B W Gillespie; C Combe; J Bommer; T Akiba; D L Mapes; E W Young; F K Port
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

6.  The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology.

Authors:  Ronald L Pisoni; Brenda W Gillespie; David M Dickinson; Kenneth Chen; Michael H Kutner; Robert A Wolfe
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

7.  Volume control and blood pressure management in patients undergoing quotidian hemodialysis.

Authors:  Gihad Nesrallah; Rita Suri; Louise Moist; Claude Kortas; Robert M Lindsay
Journal:  Am J Kidney Dis       Date:  2003-07       Impact factor: 8.860

8.  Adapting the Charlson Comorbidity Index for use in patients with ESRD.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Hude Quan; William A Ghali
Journal:  Am J Kidney Dis       Date:  2003-07       Impact factor: 8.860

9.  Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  David A Goodkin; Jennifer L Bragg-Gresham; Karl G Koenig; Robert A Wolfe; Takashi Akiba; Vittorio E Andreucci; Akira Saito; Hugh C Rayner; Kiyoshi Kurokawa; Friedrich K Port; Philip J Held; Eric W Young
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

10.  Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score.

Authors:  Peter C Austin
Journal:  Am J Epidemiol       Date:  2010-08-28       Impact factor: 4.897

View more
  51 in total

1.  A wearable artificial kidney for patients with end-stage renal disease.

Authors:  Victor Gura; Matthew B Rivara; Scott Bieber; Raj Munshi; Nancy Colobong Smith; Lori Linke; John Kundzins; Masoud Beizai; Carlos Ezon; Larry Kessler; Jonathan Himmelfarb
Journal:  JCI Insight       Date:  2016-06-02

2.  Is peritoneal dialysis still an equal option? Results of the Berlin pediatric nocturnal dialysis program.

Authors:  Julia Thumfart; Tanja Hilliger; Christina Stiny; Steffen Wagner; Uwe Querfeld; Dominik Müller
Journal:  Pediatr Nephrol       Date:  2015-01-27       Impact factor: 3.714

3.  Estimating patient-borne water and electricity costs in home hemodialysis: a simulation.

Authors:  Matthew Nickel; Wes Rideout; Nikhil Shah; Frances Reintjes; Justin Z Chen; Robert Burrell; Robert P Pauly
Journal:  CMAJ Open       Date:  2017-02-10

Review 4.  Intensive hemodialysis compared to conventional hemodialysis: looking at recent evidence in an old debate.

Authors:  Martin Aguilar; Laura Pilozzi-Edmonds; Istvan Mucsi
Journal:  Int Urol Nephrol       Date:  2013-11-01       Impact factor: 2.370

5.  Survival and hospitalization for intensive home hemodialysis compared with kidney transplantation.

Authors:  Karthik K Tennankore; S Joseph Kim; Heather J Baer; Christopher T Chan
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

6.  Managing Kidney Failure with Home Hemodialysis.

Authors:  Ali Ibrahim; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-24       Impact factor: 8.237

Review 7.  The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics.

Authors:  Jeffrey Perl; Laura M Dember; Joanne M Bargman; Teri Browne; David M Charytan; Jennifer E Flythe; LaTonya J Hickson; Adriana M Hung; Michel Jadoul; Timmy Chang Lee; Klemens B Meyer; Hamid Moradi; Tariq Shafi; Isaac Teitelbaum; Leslie P Wong; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-17       Impact factor: 8.237

8.  An Incident Cohort Study Comparing Survival on Home Hemodialysis and Peritoneal Dialysis (Australia and New Zealand Dialysis and Transplantation Registry).

Authors:  Annie-Claire Nadeau-Fredette; Carmel M Hawley; Elaine M Pascoe; Christopher T Chan; Philip A Clayton; Kevan R Polkinghorne; Neil Boudville; Martine Leblanc; David W Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-11       Impact factor: 8.237

9.  Mind the gap.

Authors:  Thomas A Golper; Rachel Fissell
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

Review 10.  How to overcome barriers and establish a successful home HD program.

Authors:  Bessie A Young; Christopher Chan; Christopher Blagg; Robert Lockridge; Thomas Golper; Fred Finkelstein; Rachel Shaffer; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.